Laura González, a former member of the N&N Group, has been awarded the PhD Extraordinary Award by Universitat Autònoma de Barcelona, for her doctoral thesis that was developed during the period 2016-2017. Laura’s thesis, “Evaluating inorganic nanoparticles in the living organism Caenorhabditis elegans”, was supervised by Anna Roig and Anna Laromaine.
Elisa carried out her PhD here at ICMAB, within the N&N Group, and in collaboration with Vall d’Hebron Research Institute (VHIR), under the supervision of Anna Roig (ICMAB) and Anna Rosell (VHIR), in the framework of the UAB PhD program.
The awards ceremony will take place on November 18, 2016, at 6.30 pm, at Hotel Campus (Edifici Blanc).
Elisa is now working in a startup biopharmaceutical company (Addex Therapeutics) in Geneva (Switzerland), which develops new molecules for the treatment of neurological diseases such as Parkinson’s and epilepsy. Elisa is investigating the effects of these molecules in humans, in different Clinical Research studies.
Congratulations Elisa!
More information about the Extraordinary PhD award resolution here.
The thesis can be found in the UAB Digital Document Repository : http://ddd.uab.cat/record/128025
The awards ceremony took place today, February 11, at the UB Paranimf, and was also the ceremony to award the epidemiologist and oncologist Francesc Xavier Bosch with the honorary doctorate (doctor honoris causa). Dr. F. Xavier Bosch is well-known for participating in the development of the HPV vaccine.